NO20010248D0 - Transdermalt plaster og topiske sammensetninger omfattende propylnorapomorfin - Google Patents

Transdermalt plaster og topiske sammensetninger omfattende propylnorapomorfin

Info

Publication number
NO20010248D0
NO20010248D0 NO20010248A NO20010248A NO20010248D0 NO 20010248 D0 NO20010248 D0 NO 20010248D0 NO 20010248 A NO20010248 A NO 20010248A NO 20010248 A NO20010248 A NO 20010248A NO 20010248 D0 NO20010248 D0 NO 20010248D0
Authority
NO
Norway
Prior art keywords
propylnorapomorphine
transdermal patch
topical compositions
topical
compositions
Prior art date
Application number
NO20010248A
Other languages
English (en)
Other versions
NO20010248L (no
Inventor
Gian Luigi Gessa
Original Assignee
Unihart Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unihart Corp filed Critical Unihart Corp
Publication of NO20010248L publication Critical patent/NO20010248L/no
Publication of NO20010248D0 publication Critical patent/NO20010248D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20010248A 1998-07-17 2001-01-15 Transdermalt plaster og topiske sammensetninger omfattende propylnorapomorfin NO20010248D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98RM000479A IT1299566B1 (it) 1998-07-17 1998-07-17 Cerotto transdermico e composizioni farmaceutiche comprendenti r (-)- norapropilapomorfina cloridrato e/o s (+) - norapropilapomorfina
PCT/IE1999/000066 WO2000003698A1 (en) 1998-07-17 1999-07-15 Transdermal patch and topical compositions comprising propylnorapomorphine

Publications (2)

Publication Number Publication Date
NO20010248L NO20010248L (no) 2001-01-15
NO20010248D0 true NO20010248D0 (no) 2001-01-15

Family

ID=11406053

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010248A NO20010248D0 (no) 1998-07-17 2001-01-15 Transdermalt plaster og topiske sammensetninger omfattende propylnorapomorfin

Country Status (10)

Country Link
US (1) US6592893B1 (no)
EP (1) EP1098637A1 (no)
JP (1) JP2002520352A (no)
CN (1) CN1195503C (no)
AU (1) AU764025B2 (no)
CA (1) CA2337516A1 (no)
IT (1) IT1299566B1 (no)
NO (1) NO20010248D0 (no)
WO (1) WO2000003698A1 (no)
ZA (1) ZA200100406B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506765B2 (en) * 2000-04-07 2003-01-14 Tap Pharmaceutical Products, Inc. Apomorphine derivatives and methods for their use
SE0002934D0 (sv) 2000-08-17 2000-08-17 Axon Biochemicals Bv New aporphine esters and in their use in therapy
DE10110953A1 (de) * 2001-03-07 2002-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von partiellen Dopamin-D2-Agonisten
WO2005041943A1 (en) * 2003-10-23 2005-05-12 Cipla Limited Transdermal pharmaceutical spray formulations comprising a vp/va copolymer and a non-aqueous vehicle
WO2006051819A1 (ja) * 2004-11-10 2006-05-18 Hisamitsu Pharmaceutical Co., Inc. 外用製剤及び貼付剤
BRPI0719307A2 (pt) * 2006-12-01 2014-02-04 Nitto Denko Corp Método para a supressão da descoloração ao longo do tempo da preparação adesiva contendo donepezil.
US20080131491A1 (en) * 2006-12-01 2008-06-05 Akinori Hanatani Percutaneously absorbable preparation
BRPI0913229A2 (pt) * 2008-05-30 2016-01-19 Nitto Denko Corp preparação adesiva contendo donepezil e embalagem da mesma
KR20110020788A (ko) * 2008-05-30 2011-03-03 에자이 알앤드디 매니지먼트 가부시키가이샤 경피 흡수 제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126616A (en) * 1975-11-10 1978-11-21 William B. Hinshaw N-propylnorapomorphine diesters
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
FR2732896B1 (fr) * 1995-04-11 1997-06-13 Prographarm Lab Forme pharmaceutique transdermique pour l'administration percutanee de l'apomorphine
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation

Also Published As

Publication number Publication date
ITRM980479A1 (it) 2000-01-17
JP2002520352A (ja) 2002-07-09
US6592893B1 (en) 2003-07-15
NO20010248L (no) 2001-01-15
AU4643499A (en) 2000-02-07
CN1195503C (zh) 2005-04-06
IT1299566B1 (it) 2000-03-16
WO2000003698A1 (en) 2000-01-27
CA2337516A1 (en) 2000-01-27
AU764025B2 (en) 2003-08-07
ZA200100406B (en) 2001-10-31
EP1098637A1 (en) 2001-05-16
ITRM980479A0 (it) 1998-07-17
CN1309558A (zh) 2001-08-22

Similar Documents

Publication Publication Date Title
NO20022334L (no) Ny sammensetning og anvendelse
ITMI981889A0 (it) Cerotto transdermico
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
NO20032753L (no) Forbindelse og anvendelse derav
NO20006604D0 (no) Fremgangsmåter og transdermale sammensetninger for lindring av smerte
NO20006488D0 (no) Sammensetning og anvendelse
DK1233964T3 (da) Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
DE69918871D1 (de) Zementzusatzmittel und Zementzusammensetzung
DE69803592D1 (de) Kristallisationshemmung in transdermalen vorrichtungen
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
BR0115102B1 (pt) Compostos 1-aril- ou 1-alquilsulfonil-heterociclilbenzazóis e composição compreendendo os mesmos
DK1189853T3 (da) Betonformulering
DK1242095T3 (da) Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf
NO20021116D0 (no) Ny sammensetning
IL138509A0 (en) Topical transdermal anesthetic formulation
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
DK1112003T3 (da) Ny sammensætning og anvendelse
PT1139761E (pt) Composicoes herbicidas e concentrados tensioactivos
NO20003067D0 (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
NO20021115L (no) Ny sammensetning
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
DK0977812T3 (da) Asfaltsammensætninger og fremgangsmåder til fremstilling deraf
NO20010248D0 (no) Transdermalt plaster og topiske sammensetninger omfattende propylnorapomorfin
NO20013085D0 (no) Fosfororganiske forbindelser og deres anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application